Clinical trials
Phase 4 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
172 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 12 |
| 2007 | 14 |
| 2008 | 7 |
| 2009 | 13 |
| 2010 | 6 |
| 2011 | 12 |
| 2012 | 11 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
| Unknown status | 28 |
| Terminated | 17 |
| Recruiting | 9 |
| Not yet recruiting | 6 |
| Withdrawn | 4 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 7 |
| Seoul National University Hospital | 7 |
| Baylor College of Medicine | 4 |
| Technische Universität Dresden | 4 |
| University of South Florida | 4 |
| Bial - Portela C S.A. | 3 |
| GlaxoSmithKline | 3 |
| IRCCS San Raffaele Roma | 3 |
| Novartis | 3 |
| Oregon Health and Science University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 172 |
| Urinary Bladder, Overactive | 7 |
| Dyskinesias | 6 |
| Parkinsonian Disorders | 5 |
| Cognitive Dysfunction | 4 |
| Dementia | 4 |
| Parasomnias | 4 |
| Gait Disorders, Neurologic | 3 |
| Movement Disorders | 3 |
| Multiple System Atrophy | 3 |
Trials
Showing 51 to 75 of 172. Each trial links to its page on Pharma Observatory.
72 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.